Estimated read time: Less than a minute
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
FOREST, Va. (AP) — Teva Pharmaceutical Industries Ltd. will supply the U.S. military with a Virginia-made vaccine to combat the spread of infectious respiratory disease in basic training camps.
Media outlets report the Army announced the $170 million contract Monday between Jerusalem-based Teva and the U.S. Defense Department.
The adenovirus vaccine is manufactured at Teva's plant in Forest.
Under the five-year contract, the company anticipates the military's nine basic training camps will need about 250,000 vaccine doses per year.
Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
